Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Cancer Prev Res (Phila). 2010 Jan;3(1):108–113. doi: 10.1158/1940-6207.CAPR-08-0225

Figure 2. Inhibition of aromatase by urolithins.

Figure 2

In vitro human placental aromatase assay was performed in the presence of 0.1 μM 3H-androstenedione and urolithin compounds (47 μM). The aromatase activity of vehicle-treated microsomes was set at 100%. The measurements were performed in triplicate. Data is expressed as percentage of activity remaining, mean ± SEM, p ≤ 0.01.